Psychotropics, PRNs & GDR—Compliance in Practice
Select tickets
Please select only one ticket type below, if you have questions call (518) 462-4800 ext. 22. |
About the event
Online registration is closed. If you would like to attend, please complete this form and return it to earmstrong@nyshfa-nyscal.org
Description The updated regulatory guidance in April 2025, once again brought the need for the LTC interdisciplinary team including the medical directors to focus on resident behaviors, ensuring accurate, substantiated mental health diagnoses, use of non-pharmacological interventions and close monitoring of psychotropic medications. CMS is not alone in monitoring the use of psychotropic medication. The Office of the Inspector General (OIG) has focused on reduction of psychotropic medications and the use of other medications such as anticonvulsants for their sedating effect. During this webinar we will discuss the impact of these regulations on the care of LTC residents with psychiatric illnesses, the importance of monitoring behaviors, the use of psychotropic medications, and the need for person centered care. We will discuss the GDR process, the importance of supporting documentation, and the need for team collaboration when medications are reduced.
Target Audience Administrators, Executive Directors, Regional Directors, Director of Nursing Services, MDS Coordinators, and Interdisciplinary Team members CEUs 1.5 CEUs is available for ALAs and LNHAs. Confirmations One day prior to the session, all registrants will be emailed:
PLEASE NOTE: Cost is per connection. Multiple participants may listen in on one connection at the cost of one registration. Multiple lines from the same facility will be invoiced an additional registration fee. Refund & Cancellation Policy No refunds will be issued after the webinar.
|
